TABLE 1.
Group 0 (N = 18) | Group 1 (N = 19) | Group 2 (N = 18) | Group 3 (N = 19) | Total (N = 74) | |
Age | |||||
-Mean (SD) | 48.111 (19.244) | 59.526 (22.860) | 66.833 (13.781) | 66.263 (12.458) | 60.257 (18.819) |
-Range | 13.000–86.000 | 23.000–94.000 | 46.000–91.000 | 40.000–85.000 | 13.000–94.000 |
Gender | |||||
-F | 9 (50.0%) | 12 (63.2%) | 9 (50.0%) | 2 (10.5%) | 32 (43.2%) |
-M | 9 (50.0%) | 7 (36.8%) | 9 (50.0%) | 17 (89.5%) | 42 (56.8%) |
Hospital admission | |||||
-No | 18 (100.0%) | 19 (100.0%) | 0 (0.0%) | 0 (0.0%) | 37 (50.0%) |
-Yes | 0 (0.0%) | 0 (0.0%) | 18 (100.0%) | 19 (100.0%) | 37 (50.0%) |
Diagnosis | |||||
-Bronchitis | 1 (5.6%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (1.4%) |
-COPD* | 1 (5.6%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (1.4%) |
-Fever | 0 (0.0%) | 2 (10.5%) | 0 (0.0%) | 0 (0.0%) | 2 (2.7%) |
-Pneumonia | 2 (11.1%) | 4 (21.1%) | 14 (77.8%) | 15 (78.9%) | 35 (47.3%) |
-Respiratory infection | 8 (44.4%) | 11 (57.9%) | 4 (22.2%) | 0 (0.0%) | 23 (31.1%) |
-Respiratory insufficiency | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 4 (21.1%) | 4 (5.4%) |
-RSC-COVID19** | 6 (33.3%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 6 (8.1%) |
-Toracic pain | 0 (0.0%) | 1 (5.3%) | 0 (0.0%) | 0 (0.0%) | 1 (1.4%) |
-Vomits | 0 (0.0%) | 1 (5.3%) | 0 (0.0%) | 0 (0.0%) | 1 (1.4%) |
Intensive units | |||||
-No | 18 (100.0%) | 19 (100.0%) | 18 (100.0%) | 0 (0.0%) | 55 (74.3%) |
-Yes | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 19 (100.0%) | 19 (25.7%) |
Ct (cycle threshold) | |||||
-Mean (SD) | 26.34 (5.17) | 27.03 (5.31) | 25.86 (4.69) | 26.38 (5.07) |
*COPD: Chronic obstructive pulmonary disease.
**RSC-COVID19: Respiratory symptoms compatible with COVID19 disease.